Hydroxychloroquine combination risky for cancer patients with COVID-19: Study
US researchers found that cancer patients with COVID-19 who were being administered with hydroxychloroquine with the antibiotic azithromycin drug combination to counter the coronavirus were three times more likely to die within 30 days than those who got either drug alone.
May 29, 2020, 06:27 AM IST
WHO pauses trial of hydroxychloroquine in COVID-19 patients due to safety concerns
The World Health Organization has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns, WHO Director General Tedros Adhanom Ghebreyesus said on Monday.
May 25, 2020, 22:51 PM IST
ICMR allows use of HCQ among healthcare workers in containment zones, non-COVID hospitals
The use of HCQ can be expanded to all healthcare workers in containment zones; healthcare workers in non-COVID hospitals; the front-line workers; for police, security forces working in containment areas and household contacts of confirmed cases.
May 23, 2020, 10:25 AM IST
India’s current production capacity of HCQ is 35-40 cr tablets a month: IDMA
Senior vice president of Indian Drug Manufacturers’ Association (IDMA), Viranchi Shah said that India’s current production capacity of Hydroxychloroquine is 35-40 crore tablets a month. While speaking to ANI, he said, “India holds almost 70% global capacity of manufacturing Hydroxychloroquine (HCQ). Our current production capacity of Hydroxychloroquine is 35-40 crore tablets a month. This is 10 times more than our requirement. There is no shortage of HCQ in India and we have sufficient amount of it to supply outside.”
Apr 24, 2020, 12:54 PM IST
